SCHEMBL23360706

SCHEMBL23360706

Cc1cc(N)c(N)cc1N1CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.54
LGMN Q99538 3/20 0.51
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
GAA P10253 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
CRHBP P24387 1/20 0.45
CRHR2 Q13324 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
THRB P10828 2/20 0.44
POLB P06746 1/20 0.44
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30168920 1.00 MAPT (0.54) MAPTLGMNHPGDTSHRNPSR1
SCHEMBL19623582 0.91 MAPT (0.52) MAPTLGMNHPGDTSHRNPSR1
SCHEMBL4461076 0.86 ALDH1A1 (0.50) MAPTLGMNHPGDTSHRNPSR1
SCHEMBL24196353 0.86 ALDH1A1 (0.50) MAPTLGMNHPGDTSHRNPSR1
SCHEMBL21032108 0.83 MAPT (0.47) MAPTLGMNHPGDTSHRNPSR1
SCHEMBL24179133 0.83 MAPT (0.47) MAPTLGMNHPGDTSHRNPSR1
SCHEMBL5327311 0.82 MAPK1 (0.55) MAPTLGMNHPGDTSHRNPSR1
SCHEMBL19170774 0.82 ALDH1A1 (0.51) MAPTLGMNHPGDTSHRNPSR1
SCHEMBL11439640 0.80 ALDH1A1 (0.56) MAPTNPSR1GAASMN1; SMN2ALDH1A1
SCHEMBL21001151 0.80 MAPT (0.71) MAPTNPSR1GAASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691970-B2 Pyrazolopyridinone compounds JANSSEN PHARMACEUTICA NV (BE) 2023-07-04 US disclosed
US-11691970-B2 Pyrazolopyridinone compounds JANSSEN PHARMACEUTICA NV (BE) 2023-07-04 US disclosed
US-11691970-B2 Pyrazolopyridinone compounds JANSSEN PHARMACEUTICA NV (BE) 2023-07-04 US disclosed
CN-111655690-B Pyrazolopyridinone compounds 詹森药业有限公司 2023-01-10 CN disclosed
EP-3713941-B1 PYRAZOLOPYRIDINONE COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2022-06-22 EP disclosed
EP-3713941-B1 PYRAZOLOPYRIDINONE COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2022-06-22 EP disclosed
US-20210147411-A1 PYRAZOLOPYRIDINONE COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2021-05-20 US disclosed
US-20210147411-A1 PYRAZOLOPYRIDINONE COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2021-05-20 US disclosed
CN-111655690-A Pyrazolopyridinone compounds 詹森药业有限公司 2020-09-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147411-A1 PYRAZOLOPYRIDINONE COMPOUNDS FGFR1, FGFR3, FGFR2 MAPT 1516/4885LGMN 4590/4885HPGD 1174/4885
US-11691970-B2 Pyrazolopyridinone compounds FGFR1, FGFR3, FGFR2 MAPT 1516/4885LGMN 4590/4885HPGD 1174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.